Hasten Biopharmaceutic Co. Ltd. (Hasten), which integrates R&D, production and commercial promotion and covers the whole industrial chain, was established in 2020. Rooted in China with a global perspective, Hasten Biopharma will connect the upstream and downstream industrial chains through the layout of "whole industry" and "globalization", as well as enrich product structure and pipelines by virtue of diversified ways. We will work closely with our stakeholders such as relevant government institutions, medical and health professionals and industry partners to continuously drive the management ecosystem of chronic diseases and geriatric-related diseases, aiming to build a leading innovative medical and healthcare enterprise in China so as to benefit more patients.